• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mutations of the SCN1A gene in acute encephalopathy

tetano

Editor, Senior Moderator
Epilepsia. 2012 Feb 6. doi: 10.1111/j.1528-1167.2011.03402.x. [Epub ahead of print]
Mutations of the SCN1A gene in acute encephalopathy.
Saitoh M, Shinohara M, Hoshino H, Kubota M, Amemiya K, Takanashi JL, Hwang SK, Hirose S, Mizuguchi M.
Source

Department of Developmental Medical Sciences, Graduate School of Medicine, University of Tokyo, Tokyo, Japan Division of Neurology, National Center for Child Health and Development, Hachioji, Japan Department of Neurology, Tokyo Metropolitan Hachioji Children's Hospital, Tokyo, Japan Department of Pediatrics, Kameda Medical Center, Kamogawa, Japan Department of Pediatrics and Research Institute for the Pathomechanisms of Epilepsy, Fukuoka University, Fukuoka, Japan.
Abstract

Purpose:  Acute encephalopathy is the most serious complication of pediatric viral infections, such as influenza and exanthema subitum. It occurs worldwide, but is most prevalent in East Asia. Recently, there have been sporadic case reports of epilepsy/febrile seizure and acute encephalopathy with a neuronal sodium channel alpha 1 subunit (SCN1A) mutation. To determine whether SCN1A mutations are a predisposing factor of acute encephalopathy, we sought to identify SCN1A mutations in a large case series of acute encephalopathy including various syndromes. Methods:  We analyzed the SCN1A gene in 87 patients with acute encephalopathy, consisting of 20 with acute necrotizing encephalopathy (ANE), 61 with acute encephalopathy with biphasic seizures and late reduced diffusion (AESD), and six with nonspecific (unclassified) acute encephalopathy. Key Findings:  Three patients had distinct point mutations. Two of them had epileptic seizures prior to acute encephalopathy. Clinical and neuroradiologic findings of acute encephalopathy were diverse among the three patients, although all had a prolonged and generalized seizure at its onset. The first patient with V982L had partial epilepsy and AESD. The second patient with M1977L had febrile seizures and nonspecific acute encephalopathy. The third patient with R1575C had no seizures until the onset of ANE. M1977L was a novel mutation, whereas the remaining two, V982L and R1575C, have previously been reported in cases of Dravet syndrome and acute encephalopathy, respectively. Significance:  These findings provide further evidence that SCN1A mutations are a predisposing factor for the onset of various types of acute encephalopathy.

Wiley Periodicals, Inc. ? 2012 International League Against Epilepsy.

PMID:
22309220
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22309220
 
Back
Top Bottom